公开(公告)号：US20220203022A1

公开(公告)日：2022-06-30

申请号：US17553699

申请日：2021-12-16

Applicant: Insulet Corporation

Inventor： David NAZZARO ,  John D'ARCO ,  Nicholas CONTE ,  Kepei SUN

IPC: A61M5/142 ,  G16H40/67 ,  G16H20/17

Abstract: An on-body drug delivery device may have one or more antennas secured outside a housing of the on-body drug delivery device for facilitating wireless communications. The one or more antennas may be secured to an adhesive pad that adheres the on-body drug delivery device to a user. Alternatively, the one or more antennas may be secured to a portion of the housing for the on-body drug delivery device. In such instances, the one or more antennas may pass through one or more holes in the housing to facilitate an electrical connection with a component, like a wireless communications transceiver, inside the housing. Alternatively, wireless communications with the one or more antennas and the component may be used.

公开(公告)号：US20210038813A1

公开(公告)日：2021-02-11

申请号：US17079393

申请日：2020-10-23

Applicant: Insulet Corporation

Inventor： Jason O'CONNOR ,  Daniel ALLIS ,  David NAZZARO ,  John R. Bussiere ,  John D'ARCO

IPC: A61M5/172 ,  G16H40/63 ,  G16H20/17 ,  A61M5/142

Abstract: Systems and methods for automatically delivering medication to a user. An automated drug delivery system may include a sensor and a wearable automated drug delivery device. The wearable automated drug delivery device may be configured to couple to the skin of a user and may include a controller and a pump. The pump may be configured to output the medication. The controller may be within the wearable automated drug delivery device. The sensor may be coupled to the user and may be configured to collect information regarding the user. The controller of the wearable automated drug delivery device may use the collected information to locally determine an amount of medication to be output from the wearable automated drug delivery device and cause delivery of the amount of medication.

公开(公告)号：US20230067014A1

公开(公告)日：2023-03-02

申请号：US17821989

申请日：2022-08-24

Applicant: INSULET CORPORATION

Inventor： Joon Bok LEE ,  John D'ARCO ,  David NAZZARO ,  Yibin ZHENG ,  Jason O'CONNOR

IPC: A61M5/315 ,  A61M5/20

Abstract: The exemplary embodiments may account for a change in potency of a medicament and adjust the dosage of medicament delivered to a user via a medicament delivery device to compensate for the change in potency. The medicament delivery device may determine the amount of change in the potency in the medicament and may make the adjustment in dosage of the medicament delivered to the user automatically without user input. The net result in that the dosage of medicament delivered to the user is better matched to the user's true need for the medicament.

公开(公告)号：US20200324048A1

公开(公告)日：2020-10-15

申请号：US16898529

申请日：2020-06-11

Applicant: Insulet Corporation

Inventor： Jason O'CONNOR ,  Daniel ALLIS ,  David NAZZARO ,  John R. Bussiere ,  John D'ARCO

IPC: A61M5/172 ,  G16H40/63 ,  G16H20/17 ,  A61M5/142

Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.

公开(公告)号：US20230173173A1

公开(公告)日：2023-06-08

申请号：US18160724

申请日：2023-01-27

Applicant: INSULET CORPORATION

Inventor： Jason O'CONNOR ,  Joon Bok LEE ,  Ian MCLAUGHLIN ,  John D'ARCO

IPC: A61M5/158 ,  A61B5/145 ,  A61B5/00 ,  A61M5/142 ,  A61M31/00

CPC classification number: A61M5/158 ,  A61B5/14532 ,  A61B5/4839 ,  A61M5/14244 ,  A61M31/002 ,  A61B2562/0219 ,  A61M2005/14208 ,  A61M2005/14252 ,  A61M2005/1585

Abstract: A drug delivery device may include an Inertial Measurement Unit (IMU) is provided. The IMU may include an accelerometer, a magnetometer, or a gyroscope. Motion parameters may be detected when the drug delivery device is shipped, being prepared for activation for use, or during use. The IMU may provide data indicative of a rapid deceleration, such as when a package containing the drug delivery device is dropped, or some other physical event experienced by the drug delivery device. The drug delivery device may also include internal or external pressure sensors or a blood glucose sensor that may coordinate with the IMU to provide additional feedback regarding the status of the device or user. A controller of the drug delivery device may generate a response depending on the particular parameters being monitored or may change device operational parameters as a result of detected system events.

公开(公告)号：US20220233765A1

公开(公告)日：2022-07-28

申请号：US17580249

申请日：2022-01-20

Applicant: Insulet Corporation

Inventor： David NAZZARO ,  John D'ARCO ,  Nicholas CONTE ,  Kepei SUN

IPC: A61M5/142

Abstract: In an exemplary embodiment, a drug delivery device is configured for Body Channel Communication (BCC). The drug delivery device may include a conductive element embedded in an adhesive patch that secures the drug delivery device to the user. This conductive element acts as a coupler to the body of the user. Another conductive element may also be provided at a face of the housing. This conductive element acts as the other end of the coupler formed with the conductive coil in the adhesive patch. The conductive coil in the adhesive patch conforms well to the user's skin surface and thus facilitates a good quality coupling with the user.

公开(公告)号：US20220192543A1

公开(公告)日：2022-06-23

申请号：US17554455

申请日：2021-12-17

Applicant: Insulet Corporation

Inventor： David NAZZARO ,  John D'ARCO ,  Nicholas CONTE ,  Kepei SUN

IPC: A61B5/145 ,  A61B5/1486 ,  A61B5/00

Abstract: Exemplary embodiments may provide an adhesive pad that is designed to be used with an on-body medical device. The adhesive pad may partially or fully surround a perimeter of the on-body medical device. The adhesive pad may be the primary mechanism or may provide an additional mechanism for helping to secure the on-body medical device to the user. In addition, the adhesive pad may include a metallic coil, such as a metal loop, that is woven into the adhesive pad or otherwise inserted into or secured to the adhesive pad. The metallic coil may play multiple roles. First, the metallic coil may act as an antenna to facilitate wireless communications with the on-body medical device, such as NFC communications. In addition, the metallic coil may serve as a power source for electric components positioned on the adhesive pad.

公开(公告)号：US20210379282A1

公开(公告)日：2021-12-09

申请号：US17403784

申请日：2021-08-16

Applicant: Insulet Corporation

Inventor： Jason O'CONNOR ,  Daniel ALLIS ,  David NAZZARO ,  John R. Bussiere ,  John D'ARCO

IPC: A61M5/172 ,  G16H40/63 ,  G16H20/17 ,  A61M5/142

Abstract: Systems and methods for automatically delivering medication to a user. An automated drug delivery system may include a sensor and a wearable automated drug delivery device. The wearable automated drug delivery device may be configured to couple to the skin of a user and may include a controller and a pump. The pump may be configured to output the medication. The controller may be within the wearable automated drug delivery device. The sensor may be coupled to the user and may be configured to collect information regarding the user. The controller of the wearable automated drug delivery device may use the collected information to locally determine an amount of medication to be output from the wearable automated drug delivery device and cause delivery of the amount of medication.